Premium
Vascular complications of total abdominal perfusion and aortic stop‐flow infusion
Author(s) -
Klein Ehud S.,
BenAri Gur Y.,
Papa Moshe Z.,
Adar Raphael,
Bass Arie
Publication year - 1996
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/(sici)1096-9098(199601)61:1<17::aid-jso5>3.0.co;2-v
Subject(s) - medicine , surgery , abdominal aorta , aorta , radiology , perfusion , femoral artery , dissection (medical) , aortic dissection , thrombosis
During a 2 year period (1992–1993), 149 patients with advanced abdominal cancer underwent total abdominal ischemic perfusion (TAP) and stop‐flow infusion (SFI) 159 times in an attempt to achieve palliation. These procedures and aortic stop‐flow infusion require insertion of balloon catheters into the abdominal aorta and inferior vena cava by a transfemoral approach. Flow is arrested for 15 minutes, during which time chemotherapeutic agents are infused into the aorta, distal to the balloon occlusion. Femoral access is by a surgical incision. The passage of the catheters is guided by fluoroscopy. Some tumor response was observed in 35% of the patients. Ten patients had major vascular complications; two iliac artery aneurysms were lacerated and required emergency repair. There were two femoral artery false aneurysms that required surgical correction, one early and one late. Aortic dissection was detected in four patients, but these did not require surgical intervention. Two patients had thrombosis distal to the occluded vessel, both required surgical intervention. To reduce the incidence of these vascular complications we recommend: (1) a clinical and vascular laboratory evaluation before the procedure, and (2) angiography of normal flow in patients with underlying vascular disease. © 1996 Wiley‐Liss, Inc.